Relationship between gonadotrophin secretion, inhibin B and spermatogenesis in oligozoospermic men treated with highly purified urinary follicle-stimulating hormone (uFSH-HP): A preliminary report

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 107, Issue 1, 2003, Pages 47-51

  Fernandez Arjona M ^a,c   Diaz J ^a   Cortes, I ^a   Gonzalez J ^a   Rodriguez, J M ^a   Alvarez, E ^b  

^a HOSPITAL SANTA BÁRBARA   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c NONE   (Spain)

Author keywords

Highly purified urinary FSH; Inhibin B; Oligozoospermia; Semen analysis; Spermatogenesis

Indexed keywords

FOLLITROPIN; GONADOTROPIN; INHIBIN B; NEOFERTINORM HP;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GONADOTROPIN RELEASE; HORMONE BLOOD LEVEL; HUMAN; MALE; OLIGOSPERMIA; PARAMETER; PRIORITY JOURNAL; PROGNOSIS; REPRODUCTION; SERTOLI CELL; SPERM; SPERMATOGENESIS; SPERMIOGRAM; TESTIS FUNCTION;

EID: 0037467460     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(02)00313-5     Document Type: Article

References (20)

1. Bartoov B., Eltes F., Lunenfeld E., Har-Even D., Lederman H., Lunenfeld B. Sperm quality of subfertile males before and after treatment with human follicle-stimulating hormone. Fertil. Steril. 61:1994;727-734.
2. Wallace E.M., Healy D.L. Inhibins and activins: roles in clinical practice. Br. J. Obstet. Gynaecol. 103:1996;945-956.
3. De Kretser D., McFarlane J.R. Inhibin in the male. J. Androl. 17:1996;179-182.
4. Balasch J., Gonzalez-Merlo J. La inhibina y la practica clinica en obstetricia y ginecologia. Prog. Obstet. Gynecol. 49:1999;699-702.
5. Bohring C., Krause W. Serum levels of inhibin B in men with different causes of spermatogenic failure. Andrologia. 31:1999;137-141.
6. Handelsman D.J., Turner L., Boylan M.et al. Pharmacokinetics of human follicle stimulating hormone in gonadotrophin deficient men. J. Clin. Endocrinol. Metab. 80:1995;1657-1663.
7. Howless C.M., Loumaye E., Giroud D., Luyet G. Multiple follicular development and ovarian steroidogenesis following subcutaneous administration of a highly purified urinary FSH preparation in pituitary desensitized women undergoing IVF: a multicentre European phase III study. Hum. Reprod. 9:1994;424-430.
8. Anawalt B.D., Bebb R.A., Matsumoto A.M., Groome N.P., Illingworth P.J., McNeilly A.S.et al. Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J. Clin. Endocrinol. Metab. 81:1996;3341-3345.
9. Illingworth P.J., Groome N.P., Byrd W., Rainey W.E., McNeilly A.S., Mather J.P.et al. Inhibin B: a likely candidate for the physiologically important form of inhibin in men. J. Clin. Endocrinol. Metab. 81:1996;1321-1325.
10. Anderson R.A., Wallacw E.M., Groome N.P., Bellis A.J., Wu F.C.W. Physiological relationships between inhibin B, follicle stimulating hormone secretion and spermatogenesis in normal men and response to gonadotrophin suppression by exogenous testosterone. Hum. Reprod. 12:1997;746-751.
11. De Kretser D.M., McLachlan R.I., Robertson D.M.et al. Serum inhibin levels in normal men and men with testicular disorders. J. Endocrinol. 120:1989;517-523.
12. Sheckter C.B., McLachlan R.I., Tenove J.S.et al. Serun inhibin concentrations rise during GnRH treatment of men with idiopathic hypogonadotrophic hypogonadism. J. Clin. Endocrinol. Metab. 67:1988;1221-1224.
13. McLachlan R.I., Matsumoto A.M., Burger H.G.et al. Follicle-stimulating hormone is required for quantitatively normal inhibin secretion in men. J. Clin. Endocrinol. Metab. 67:1988;1305-1308.
14. Ben-Rafael Z., Farhi J., Feldberg D.et al. Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization: the impact on sperm microstructure and fertilization potential. Fertil. Steril. 73:2000;24-30.
15. Dirnfeld M., Katz G., Calderón I.et al. Es beneficioso el tratamiento adyuvante con hormona estimulante de los folículos pura en algunos casos de esterilidad humana durante la fertilización in vitro. Eur. J. Obstet. Gynecol. Reprod. Biol. (Ed. Española). 1:2001;209-213.
16. Word Health Organization. Laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 4th ed. Cambridge: Cambridge University Press; 1999.
17. Diaz J., Fernandez-Arjona M., Perandones C., Serrano E., Frau C., Cortes I.et al. Reference intervals for biochemistry parameters for evaluation of oxidative stress in human sperm. Clin. Chem. 44:1998;2197-2199.
18. Kliesch S., Behre H.M., Nieschlag E. High efficacy of gonadotrophin or pulsatile gonadotrophin releasing hormone treatment in hypogonadotrophic hypogonadal men. Eur. J. Endocrinol. 131:1994;347-354.
19. Foresta C., Bettella A., Ferlin A., Garolla A., Rossato M. Evidence for stimulatory role of follicle-stimulating hormone on the spermatogonial population in adult males. Fertil. Steril. 69:1998;636-642.
20. Canale D., Giorgi P.M., Menchini Fabris G.F. Trattamento con FSH puro nellïnfertilitá maschile: risultati di uno studio clinico multicentrico. Giornate Andrologiche Italiane Bologna. 16/17:1992;23-29.